BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 12430857)

  • 1. Autologous stem cell transplants in treatment of multiple sclerosis: where we stand and future prospects.
    Fassas A
    Int J Hematol; 2002 Aug; 76 Suppl 1():223-5. PubMed ID: 12430857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stem cell transplantation for multiple sclerosis: what is the evidence?
    Fassas A; Kimiskidis VK
    Blood Rev; 2003 Dec; 17(4):233-40. PubMed ID: 14556778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose immunosuppression and autologous hematopoietic stem cell rescue for severe multiple sclerosis.
    Fassas A; Kazis A
    J Hematother Stem Cell Res; 2003 Dec; 12(6):701-11. PubMed ID: 14977479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stem cell transplantation for autoimmune diseases.
    Gratwohl A; Passweg J; Gerber I; Tyndall A;
    Best Pract Res Clin Haematol; 2001 Dec; 14(4):755-76. PubMed ID: 11924920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autologous hemopoietic stem cell transplantation for multiple sclerosis: is it worthwile?
    Fassas A; Mancardi GL
    Autoimmunity; 2008 Dec; 41(8):601-10. PubMed ID: 18958762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autologous stem-cell transplantation in malignant multiple sclerosis: a case with a favorable long-term outcome.
    Kimiskidis V; Sakellari I; Tsimourtou V; Kapina V; Papagiannopoulos S; Kazis D; Vlaikidis N; Anagnostopoulos A; Fassas A
    Mult Scler; 2008 Mar; 14(2):278-83. PubMed ID: 17942513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stem cell transplantation for autoimmune disorders. Multiple sclerosis.
    Fassas A; Nash R
    Best Pract Res Clin Haematol; 2004 Jun; 17(2):247-62. PubMed ID: 15302338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autologous Hematopoietic Cell Transplantation for Treatment-Refractory Relapsing Multiple Sclerosis: Position Statement from the American Society for Blood and Marrow Transplantation.
    Cohen JA; Baldassari LE; Atkins HL; Bowen JD; Bredeson C; Carpenter PA; Corboy JR; Freedman MS; Griffith LM; Lowsky R; Majhail NS; Muraro PA; Nash RA; Pasquini MC; Sarantopoulos S; Savani BN; Storek J; Sullivan KM; Georges GE
    Biol Blood Marrow Transplant; 2019 May; 25(5):845-854. PubMed ID: 30794930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autologous hemopoietic stem cell transplantation in the treatment of multiple sclerosis: rationale and clinical experience.
    Fassas A; Kimiskidis VK
    J Neurol Sci; 2004 Aug; 223(1):53-8. PubMed ID: 15261561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autologous hematopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: comparison with secondary progressive multiple sclerosis.
    Casanova B; Jarque I; Gascón F; Hernández-Boluda JC; Pérez-Miralles F; de la Rubia J; Alcalá C; Sanz J; Mallada J; Cervelló A; Navarré A; Carcelén-Gadea M; Boscá I; Gil-Perotin S; Solano C; Sanz MA; Coret F
    Neurol Sci; 2017 Jul; 38(7):1213-1221. PubMed ID: 28396953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose immunoablative therapy with hematopoietic stem cell support in the treatment of severe autoimmune disease: current status and future direction.
    Tyndall A; Koike T
    Intern Med; 2002 Aug; 41(8):608-12. PubMed ID: 12211526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intense immunosuppression followed by autologous stem cell transplantation in severe multiple sclerosis.
    Capello E; Saccardi R; Murialdo A; Gualandi F; Pagliai F; Bacigalupo A; Marmont A; Uccelli A; Inglese M; Bruzzi P; Sormani MP; Cocco E; Meucci G; Massacesi L; Bertolotto A; Lugaresi A; Merelli E; Solari A; Filippi M; Mancardi GL;
    Neurol Sci; 2005 Dec; 26 Suppl 4():S200-3. PubMed ID: 16388358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hematopoietic stem cell transplantation for multiple sclerosis. A retrospective multicenter study.
    Fassas A; Passweg JR; Anagnostopoulos A; Kazis A; Kozak T; Havrdova E; Carreras E; Graus F; Kashyap A; Openshaw H; Schipperus M; Deconinck E; Mancardi G; Marmont A; Hansz J; Rabusin M; Zuazu Nagore FJ; Besalduch J; Dentamaro T; Fouillard L; Hertenstein B; La Nasa G; Musso M; Papineschi F; Rowe JM; Saccardi R; Steck A; Kappos L; Gratwohl A; Tyndall A; Samijn J;
    J Neurol; 2002 Aug; 249(8):1088-97. PubMed ID: 12195460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autologous stem cell transplantation in progressive multiple sclerosis--an interim analysis of efficacy.
    Fassas A; Anagnostopoulos A; Kazis A; Kapinas K; Sakellari I; Kimiskidis V; Smias C; Eleftheriadis N; Tsimourtou V
    J Clin Immunol; 2000 Jan; 20(1):24-30. PubMed ID: 10798604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitoxantrone: a review of its use in multiple sclerosis.
    Scott LJ; Figgitt DP
    CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term outcomes of autologous hematopoietic stem cell transplantation with reduced-intensity conditioning in multiple sclerosis: physician's and patient's perspectives.
    Shevchenko JL; Kuznetsov AN; Ionova TI; Melnichenko VY; Fedorenko DA; Kurbatova KA; Gorodokin GI; Novik AA
    Ann Hematol; 2015 Jul; 94(7):1149-57. PubMed ID: 25711670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autologous hematopoietic stem cell transplantation in combination with immunoablative protocol in secondary progressive multiple sclerosis--A 10-year follow-up of the first transplanted patient.
    Obradović D; Tukić L; Radovinović-Tasić S; Petrović B; Elez M; Ostojić G; Balint B
    Vojnosanit Pregl; 2016 May; 73(5):504-8. PubMed ID: 27430119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autologous hematopoietic stem cell transplantation for pediatric multiple sclerosis: a registry-based study of the Autoimmune Diseases Working Party (ADWP) and Pediatric Diseases Working Party (PDWP) of the European Society for Blood and Marrow Transplantation (EBMT).
    Burman J; Kirgizov K; Carlson K; Badoglio M; Mancardi GL; De Luca G; Casanova B; Ouyang J; Bembeeva R; Haas J; Bader P; Snowden J; Farge D
    Bone Marrow Transplant; 2017 Aug; 52(8):1133-1137. PubMed ID: 28319075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autologous hematopoietic stem cell transplantation in multiple sclerosis: a phase II trial.
    Mancardi GL; Sormani MP; Gualandi F; Saiz A; Carreras E; Merelli E; Donelli A; Lugaresi A; Di Bartolomeo P; Rottoli MR; Rambaldi A; Amato MP; Massacesi L; Di Gioia M; Vuolo L; Currò D; Roccatagliata L; Filippi M; Aguglia U; Iacopino P; Farge D; Saccardi R; ;
    Neurology; 2015 Mar; 84(10):981-8. PubMed ID: 25672923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autologous haematopoietic stem cell transplantation with an intermediate intensity conditioning regimen in multiple sclerosis: the Italian multi-centre experience.
    Mancardi GL; Sormani MP; Di Gioia M; Vuolo L; Gualandi F; Amato MP; Capello E; Currò D; Uccelli A; Bertolotto A; Gasperini C; Lugaresi A; Merelli E; Meucci G; Motti L; Tola MR; Scarpini E; Repice AM; Massacesi L; Saccardi R;
    Mult Scler; 2012 Jun; 18(6):835-42. PubMed ID: 22127896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.